Clinical trials

Learn more about our clinical trials focusing on the study of inhaled therapies for the treatment of PAH and PH-ILD.

See our clinical trials

Investigator-initiated trials

If you have a proposal for an investigator-initiated trial (IIT), we encourage you to get in touch. 

Propose an IIT

Commercial products

YUTREPIA™ (treprostinil) inhalation powder

YUTREPIA is an FDA-approved, inhaled dry-powder formulation of treprostinil indicated for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Delivered through a convenient, low-resistance, palm-sized device, YUTREPIA was designed using Liquidia’s PRINT® technology. PRINT enables the development of drug particles that are precise and uniform in size, shape and composition, and that are engineered for enhanced deposition in the lung following oral inhalation.

EXPLORE YUTREPIA (TREPROSTINIL) INHALATION POWDER


See Prescribing Information

Report an Adverse Event 

To report SUSPECTED ADVERSE REACTIONS, contact Liquidia Technologies, Inc. at 1-888-393-LQDA (5732) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

YUTREPIA PRINT particles

  • 1.3 μm in size
  • Precisely engineered particles
  • Trefoil shape

Treprostinil Injection

Liquidia promotes the appropriate use of Sandoz® Treprostinil Injection in the United States in conjunction with its commercial partner, Sandoz, Inc. (Sandoz), which holds the Abbreviated New Drug Application (ANDA) with the FDA.

Treprostinil Injection is a fully substitutable AP-rated generic formulation of Remodulin® (treprostinil) Injection. Treprostinil Injection is therapeutically equivalent to Remodulin.

Remodulin® is a registered trademark of United Therapeutics Corporation.

Explore Treprostinil injection 


See Prescribing Information

Report an Adverse Event

Corporate social responsibility

Our core mission is to develop and deliver innovative medical products for unmet patient needs and help improve their lives. In this context, corporate social responsibility is vitally important, not just for our mission, but for who we are as a company. In service of this mission, we invite organizations to submit requests for support, including charitable donations or requests for medical or educational research grants.

Access Our CSR Application Portal

Interested in learning more about our products and science? 

Request to be contacted by a member of our medical affairs team.

Contact Us